Sign In
Buy BBH
$185.77
+4.04 (+2.22%)
At Close: Jun 03, 2026
Risk-On Sentiments Are Back: ETFs to Play
07:30pm, Monday, 11'th Nov 2019
The global market has been rallying hard since October. Investors can thus bet on these high-flying ETFs.
Biotech ETFs in Focus on Impressive Q3 Earnings Results
10:05pm, Monday, 04'th Nov 2019
Let's take a look at some ETFs with wide exposure to a few biotechnological companies which released solid Q3 earnings results recently.
Value Biotech ETFs & Stocks to Buy Now
06:00pm, Monday, 04'th Nov 2019
Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.
Top-Performing Biotech ETFs YTD
09:46pm, Tuesday, 03'rd Sep 2019
Increasing M&A; deals, growing AI dominance and favorable regulatory tidings continue to boost the biotech stocks. Accordingly, we take a look at biotech ETFs gaining more than 10% year to date.
Amgen to Buy Celgene's Otezla: 5 ETF Drugs
02:05pm, Tuesday, 27'th Aug 2019
Amgen agreed to buy psoriasis and psoriatic arthritis drug Otezla from Celgene for $13.4 billion in cash.
Strong July Gives Way To Volatile August As Trade War Escalates
12:00am, Wednesday, 07'th Aug 2019Biotech ETFs in Focus on Impressive Q2 Earnings Results
08:22pm, Tuesday, 06'th Aug 2019
Let's take a look at some ETFs with wide exposure to a few biotechnological companies which released solid Q2 earnings results recently.
AbbVie to Buy Allergan: Prescribed ETFs
03:00pm, Wednesday, 26'th Jun 2019
AbbVie has agreed to buy Botox-maker Allergan for $63 billion in a cash-and-stock deal. The news has put the spotlight on a number of healthcare ETFs.
3 Large-Cap Biotech Stocks to Buy for Massive Gains
03:49pm, Wednesday, 19'th Jun 2019
Do you want to find the next Apple (NASDAQ:AAPL) or Amazon (NASDAQ:AMZN)? My advice is that you should set your sights lower, not higher and put some cash to work in three down, but not out heavyweigh
